Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Molecular Mechanisms of Small Cell Lung Cancer Brain Metastasis

Award Number: F31CA290763
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 06/09/2025
PERIOD OF PERFORMANCE END DATE: 06/08/2027

Group Awards By:

View Award Description

Molecular Mechanisms of Small Cell Lung Cancer Brain Metastasis - PROJECT SUMMARY This proposal focuses on the molecular and cellular mechanisms of metastasis to the brain in small-cell lung cancer (SCLC), one of the most fatal forms of human cancer. Brain metastases are very frequent and a major cause of morbidity and mortality in SCLC patients. It has proven to be extremely challenging to investigate SCLC brain metastasis because surgery is very rarely performed to remove brain metastases in SCLC patients. There is also a dearth of pre-clinical models to study SCLC brain metastasis. In previous work using pre-clinical mouse models and intracranial injections of SCLC cells, we have found an upregulation of neuronal programs in SCLC cells during metastatic progression. Our preliminary data further indicate that this induction of neuronal programs endows SCLC cells with the ability to functionally interact with various cell types in the brain microenvironment, thereby promoting the ability of SCLC cells to grow in the brain. Mechanistically, this upregulation of neuronal programs is often due to the upregulation of the transcription factor NFIB, a known regulator of neuronal programs in the developing brain. My goal is to further investigate key cellular and molecular mechanisms of SCLC brain metastasis. I propose two Specific Aims. First, because ~15% of patients with SCLC have brain metastases at the time of their cancer diagnosis, it is important to investigate the mechanisms of SCLC growth in the brain. I will use intracranial injections of SCLC cells to model the growth of brain metastases in the brain of patients with SCLC. Using these cell models, I will perform in vivo CRISPR/Cas9 knockout screens focusing on candidates with known functions in neuronal biology during brain development. In parallel, I will perform similar screens in subcutaneous tumors to identify genes that are important for growth of SCLC specifically in the brain. A pilot screen has identified Leucine-rich repeat-containing 4B (LRRC4B, also known as Netrin-G ligand-3, NGL3), a synaptic adhesion molecule known for its involvement in excitatory synapse stability, to be important for SCLC growth in the brain. The role of LRRC4B will be investigated using gain- and loss-of-function studies in SCLC cell lines to understand its potential in facilitating interactions between SCLC cells and cells within the brain microenvironment. I will also use co-culture assays with murine neurons to investigate the role of LRRC4B in the functional interactions between SCLC cells and neurons. Second, because ~70% have brain metastases at the time of death from ~15% at the time of diagnosis, it is important to also investigate how new metastases are generated in the brain of patients with SCLC. I have identified human cell lines with brain tropism in mice. I will perform serial transplantation in the brain to enrich for brain metastasis phenotypes. I will also use these cell models to assess the importance of candidate genes, including NFIB, in the metastatic seeding of SCLC cells to the brain. The proposed experiments will uncover key genes and pathways that contribute to the striking ability of SCLC to metastasize to the brain and will identify mechanisms of SCLC brain metastasis that may serve as the basis to develop new strategies to treat SCLC patients with brain metastasis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $46,647 )
2026	2026	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Research Manpower	000	2	5/1/2026	NON-COMPETING CONTINUATION	$46,647
														Subtotal = $46,647

Issue Date FY: 2025 ( Subtotal = $46,071 )
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Research Manpower	001	1	6/3/2025	NEW	$0
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Cancer Research Manpower	000	1	6/3/2025	NEW	$46,071
														Subtotal = $46,071

Grand Total All Awards = $92,718

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Molecular Mechanisms of Small Cell Lung Cancer Brain Metastasis

Award Number: F31CA290763

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 06/09/2025

PERIOD OF PERFORMANCE END DATE: 06/08/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer